Citadel Advisors »

Conduit Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $23k 190k 0.12
2023-12-31 $75k 17k 4.55

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Conduit Pharmaceuticals

Barclays
BlackRock
BlackRock
Geode Capital Management
Vanguard Group
Citadel Advisors
Northern Trust
New York State Common Retirement Fund
State Street Corporation
Morgan Stanley
Charles Schwab Investment Management
Bridgeway Capital Management
JustInvest
SG Americas Securities
AQR Capital Management

View all funds holding Conduit Pharmaceuticals